Literature DB >> 22114780

Combating inappropriate use of medicines.

Kathleen Anne Holloway1.   

Abstract

Globally, it is possible that less than half of all patients are treated in compliance with guidelines and more than half of all patients fail to take their medicines as prescribed or dispensed. Such inappropriate use is wasteful of resources and causes patient harm in terms of lack of satisfactory outcome, serious adverse events and increased antimicrobial resistance. Combating inappropriate use of medicines involves four major steps: measuring the use of medicines; identifying the determinants of inappropriate use; developing, implementing and evaluating the impact of interventions to improve the use of medicines while taking into account the factors underlying inappropriate use; and working towards an enabling policy framework that encourages appropriate use. Global evidence on how to effectively combat inappropriate use of medicines is discussed herein, with reference to the aforementioned four steps. Most interventions undertaken to combat inappropriate use of medicines have been educational in nature, have had a relatively small impact and have not taken into account the determinants of behavior. A combination of interventions, involving managerial as well as educational components, appears to be more effective than a single intervention. Less than half of countries have a policy framework that actively encourages appropriate use of medicines. Since health systems are varied and complex, a nationally coordinated package of interventions and policies, contextualized to each country, will be needed to have any substantial impact on medicine use. There is now increasing global awareness of the need to strengthen health systems, to have national coordination to combat inappropriate use of medicines and to have coordination of international aid to developing countries in order to ensure it contributes to combating inappropriate use of medicines. The opportunities this presents for combating inappropriate use of medicines are discussed in this article.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22114780     DOI: 10.1586/ecp.11.14

Source DB:  PubMed          Journal:  Expert Rev Clin Pharmacol        ISSN: 1751-2433            Impact factor:   5.045


  23 in total

1.  Antibiotics Smart Use: a workable model for promoting the rational use of medicines in Thailand.

Authors:  Nithima Sumpradit; Pisonthi Chongtrakul; Kunyada Anuwong; Somying Pumtong; Kedsenee Kongsomboon; Parichart Butdeemee; Jurairat Khonglormyati; Santi Chomyong; Parnuchote Tongyoung; Suraphol Losiriwat; Piyanooch Seesuk; Pongthep Suwanwaree; Viroj Tangcharoensathien
Journal:  Bull World Health Organ       Date:  2012-09-27       Impact factor: 9.408

2.  Exit-Knowledge About Dispensed Medications and Associated Factors Among Patients Attending the Outpatient Pharmacy of Ambo General Hospital, Western Ethiopia.

Authors:  Endalkachew Mekonnen Eticha; Workineh Diriba Gemechu
Journal:  Patient Prefer Adherence       Date:  2021-01-06       Impact factor: 2.711

3.  Availability of medicines in public sector health facilities of two North Indian States.

Authors:  Shankar Prinja; Pankaj Bahuguna; Jaya Prasad Tripathy; Rajesh Kumar
Journal:  BMC Pharmacol Toxicol       Date:  2015-12-23       Impact factor: 2.483

4.  Where are we now: assessing the price, availability and affordability of essential medicines in Delhi as India plans free medicine for all.

Authors:  Anita Kotwani
Journal:  BMC Health Serv Res       Date:  2013-07-25       Impact factor: 2.655

5.  Access to antibiotics in New Delhi, India: implications for antibiotic policy.

Authors:  Anita Kotwani; Kathleen Holloway
Journal:  J Pharm Policy Pract       Date:  2013-08-12

6.  Evaluation of Rational Use of Medicine Using WHO/INRUD Core Drug Use Indicators at Teda and Azezo Health Centers, Gondar Town, Northwest Ethiopia.

Authors:  Faisel Dula Sema; Esubalew Delie Asres; Belaynesh Dubale Wubeshet
Journal:  Integr Pharm Res Pract       Date:  2021-06-21

7.  Antimicrobial drug prescribing patterns for community-acquired pneumonia in hospitalized patients: A retrospective pilot study from New Delhi, India.

Authors:  Anita Kotwani; Santosh Kumar; Prafulla Kumar Swain; J C Suri; S N Gaur
Journal:  Indian J Pharmacol       Date:  2015 Jul-Aug       Impact factor: 1.200

8.  An evaluation of prescribing practices for community-acquired pneumonia (CAP) in Mongolia.

Authors:  Gereltuya Dorj; Delia Hendrie; Richard Parsons; Bruce Sunderland
Journal:  BMC Health Serv Res       Date:  2013-10-03       Impact factor: 2.655

9.  WHO essential medicines policies and use in developing and transitional countries: an analysis of reported policy implementation and medicines use surveys.

Authors:  Kathleen Anne Holloway; David Henry
Journal:  PLoS Med       Date:  2014-09-16       Impact factor: 11.069

10.  The Impact of WHO Essential Medicines Policies on Inappropriate Use of Antibiotics.

Authors:  Kathleen Anne Holloway; Laura Rosella; David Henry
Journal:  PLoS One       Date:  2016-03-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.